Moderna fourth-quarter revenue beats estimates
Tweet
Share
E-mailGet Alerts MRNA Hot Sheet
Join SI Premium – FREE
Investing.com -- Moderna Inc (NASDAQ: MRNA) has reported a steep drop in fourth-quarter revenue to $2.81 billion, but still topped average analyst expectations.
Shares in the U.S. drugmaker were higher in premarket trading on Thursday.
This is a developing story. Please check back later for updates.
You May Also Be Interested In
- Former Toyota chairman Hiroshi Okuda dies at 93
- Riot, NIQ surge, On Holding tumbles premarket
- Erasca, Inc. (ERAS) Misses Q2 EPS by 3c
Create E-mail Alert Related Categories
Earnings, InvestingSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
